Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IIIOngoingJan 8, 2025Polyvinyl Alcohol Ophthalmic Solution 1.4%LABELING: LABEL MIX-UPAvKARE · D-0176-2025Class IIIOngoingJan 8, 2025Carboxymethylcellulose Sodium Ophthalmic Solution 0.5% Moisturizing Lubricant Eye DropsLABELING: LABEL MIX-UPAvKARE · D-0175-2025Class IITerminatedJan 8, 2025phenylephrine in 0.9% Sodium Chloride InjLack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.Hikma Injectables USA Inc · D-0174-2025Class IITerminatedJan 8, 2025ketamine inj 50 mg per 1 mLLack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.Hikma Injectables USA Inc · D-0173-2025Class IIOngoingJan 8, 2025Dapsone Gel 7.5%CrystallizationViona Pharmaceuticals Inc · D-0172-2025Class IIOngoingJan 8, 2025Dapsone Gel 7.5%CrystallizationViona Pharmaceuticals Inc · D-0171-2025Class IOngoingJan 8, 2025FORCE FOREVER 400mg TabletsMarketed without an approved NDA/ANDA. FDA analysis found the product to be tainted with Diclofenac and Dexamethasone.GNMart LLC · D-0170-2025Class IIITerminatedJan 8, 2025Atropine Sulfate Ophthalmic SolutionFailed Impurities/Degradation SpecificationsSomerset Therapeutics LLC · D-0169-2025Class IIOngoingJan 8, 2025Nitrofurantoin CapsulesFailed Dissolution SpecificationsAvKARE · D-0168-2025Class IITerminatedJan 8, 2025Levothyroxine Sodium TabletsFailed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.Lupin Pharmaceuticals Inc. · D-0167-2025Class IIOngoingJan 1, 2025UMARY ACID HYALURONICcGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there...Mxbbb · D-0166-2025Class IIOngoingJan 1, 2025Duloxetine Delayed-Release CapsulesCGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.RemedyRepack Inc. · D-0165-2025Class IITerminatedJan 1, 2025Kit for the Preparation of Technetium Tc 99m Sestamibi InjectionLack of Assurance of Sterility; Improper crimps on vials impacting the integrity of the productCurium US, LLC · D-0164-2025Class IITerminatedJan 1, 2025DULoxetine DR USPCGMP Deviations: the presence of a Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Duloxetine above the interim acceptable intake limitPD-Rx Pharmaceuticals, Inc. · D-0163-2025Class IIOngoingJan 1, 2025Duloxetine Delayed-Release CapsulesCGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.Breckenridge Pharmaceutical, Inc · D-0162-2025Class IIOngoingJan 1, 2025Duloxetine Delayed-Release CapsulesCGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.Breckenridge Pharmaceutical, Inc · D-0161-2025Class IICompletedJan 1, 2025chlorproMAZINE Hydrochloride TabletsCGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.Glenmark Pharmaceuticals Inc., USA · D-0160-2025Class IICompletedJan 1, 2025chlorproMAZINE Hydrochloride TabletsCGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.Glenmark Pharmaceuticals Inc., USA · D-0159-2025Class IIOngoingJan 1, 2025Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.Amerisource Health Services LLC · D-0158-2025Class IIOngoingJan 1, 2025Duloxetine Delayed-Release Capsules USPCGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.Amerisource Health Services LLC · D-0157-2025Class IIOngoingJan 1, 2025Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.Amerisource Health Services LLC · D-0156-2025Class IIOngoingJan 1, 2025Duloxetine Delayed-Release Capsules USPCGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.Amerisource Health Services LLC · D-0155-2025Class IIOngoingDec 25, 2024Olanzapine TabletsFailed Impurities/Degradation SpecificationsMacleods Pharmaceuticals Ltd · D-0154-2025Class IITerminatedDec 25, 2024PROFESSIONAL Regener-EyesLack of Sterility AssuranceRegenerative Processing Plant, LLC · D-0153-2025Class IITerminatedDec 25, 2024LITE Regener-EyesLack of Sterility AssuranceRegenerative Processing Plant, LLC · D-0152-2025Class IIOngoingDec 25, 2024VCF, Vaginal Contraceptive GelCGMP deviations: out of specifications for assayApothecus Pharmaceutical Corp. · D-0151-2025Class IIOngoingDec 25, 2024Dihydroergotamine Mesylate InjectionDiscolorationProvepharm Inc. · D-0150-2025Class IIOngoingDec 25, 2024Nebivolol TabletsCGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso Nebivolol above acceptable intake (AI) limit.Aurobindo Pharma USA Inc · D-0149-2025Class IITerminatedDec 25, 2024Henry ScheinCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing...Keystone Industries · D-0148-2025Class IITerminatedDec 25, 2024Ipana, 20% Benzocaine Topical GelCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing...Keystone Industries · D-0147-2025Class IITerminatedDec 25, 2024Quala Dental ProductsCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing...Keystone Industries · D-0146-2025Class IITerminatedDec 25, 2024safco, SensiCaine UltraCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing...Keystone Industries · D-0145-2025Class IITerminatedDec 25, 2024Pearson QualityCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing...Keystone Industries · D-0144-2025Class IITerminatedDec 25, 2024BurkhartCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing...Keystone Industries · D-0143-2025Class IITerminatedDec 25, 2024Health-TecCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing...Keystone Industries · D-0142-2025Class IITerminatedDec 25, 2024Patterson DentalCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing...Keystone Industries · D-0141-2025Class IITerminatedDec 25, 2024Dental CityCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing...Keystone Industries · D-0140-2025Class IITerminatedDec 25, 2024Primo, Topical Anesthetic gelCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing...Keystone Industries · D-0139-2025Class IITerminatedDec 25, 2024M&S Dental Supply Co LLCCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing...Keystone Industries · D-0138-2025Class IITerminatedDec 25, 2024Gelato, Benzocaine 20% Topical Gel Anesthetic GelCGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing...Keystone Industries · D-0137-2025

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.